iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | BTEERegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 16,6 | 6,9 | -6,1 | 2,5 | -1,5 | |
+/-Kat | -2,2 | 10,0 | 6,7 | 1,2 | 0,8 | |
+/-Indeks | -8,8 | 0,1 | -3,1 | -7,7 | -9,6 | |
Kategori: Sektor - Bioteknologi, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Biotechnolo... |
Oversigt | ||
Closing Price 13-05-2024 | USD 6,37 | |
Kursændring 1 dag | 0,56% | |
Morningstar Kategori™ | Sektor - Bioteknologi, Aktier | |
Omsætning | 453 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BDZVHG35 | |
Markedsværdi i alt (mio.) 13-05-2024 | USD 509,13 | |
Seneste TNA(mio.) 13-05-2024 | USD 35,21 | |
Løbende omkostning 18-04-2024 | 0,35% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | BTEE |
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. |
Returns | ||||||||||||||||
|
Management | ||
Manager navn Startdato | ||
- - | ||
Startdato 05-03-2018 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
NASDAQ Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | BTEE | 10-05-2024 |
|
|
Top 5 placeringer | Sektor | % |
Amgen Inc | Healthcare | 9,37 |
Regeneron Pharmaceuticals Inc | Healthcare | 8,34 |
Vertex Pharmaceuticals Inc | Healthcare | 8,31 |
Gilead Sciences Inc | Healthcare | 7,57 |
AstraZeneca PLC ADR | Healthcare | 4,75 |
Øget Mindsket Ny siden sidste portefølje | ||
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | BTEE |